BACKGROUND: We examined the sustained efficacy of a group-based cognitive-behavioural stress management (CBSM) intervention in comparison to a modified wait-list control condition on measures of mood, coping and social support in mildly symptomatic HIV-positive homosexual and bisexual men. Participants were recruited largely during the era prior to highly active antiretroviral therapy (HAART; 1992-1997). METHODS: Men were randomized to either a 10-week, group-based CBSM intervention (n = 83) or a psychoeducational seminar group (n = 46). All participants completed a battery of psychosocial questionnaires administered by a research assistant at baseline, immediately following the 10-week CBSM intervention period, and at a 6-month follow-up. RESULTS: Men in the CBSM group maintained previously observed effects on depressive symptoms and perceived social support. These sustained effects of CBSM on depressive symptoms were mediated by 10-week increases in cognitive coping (i.e. positive reframing). DISCUSSION: CBSM appears to be a potentially efficacious treatment that reduces and maintains lower levels of depressive symptoms and enhances social support in HIV-positive homosexual and bisexual men. In particular, changes in positive reframing during the 10-week intervention period remain a crucial factor contributing to sustained reductions in depressive symptoms.
RCT Entities:
BACKGROUND: We examined the sustained efficacy of a group-based cognitive-behavioural stress management (CBSM) intervention in comparison to a modified wait-list control condition on measures of mood, coping and social support in mildly symptomatic HIV-positive homosexual and bisexual men. Participants were recruited largely during the era prior to highly active antiretroviral therapy (HAART; 1992-1997). METHODS:Men were randomized to either a 10-week, group-based CBSM intervention (n = 83) or a psychoeducational seminar group (n = 46). All participants completed a battery of psychosocial questionnaires administered by a research assistant at baseline, immediately following the 10-week CBSM intervention period, and at a 6-month follow-up. RESULTS:Men in the CBSM group maintained previously observed effects on depressive symptoms and perceived social support. These sustained effects of CBSM on depressive symptoms were mediated by 10-week increases in cognitive coping (i.e. positive reframing). DISCUSSION: CBSM appears to be a potentially efficacious treatment that reduces and maintains lower levels of depressive symptoms and enhances social support in HIV-positive homosexual and bisexual men. In particular, changes in positive reframing during the 10-week intervention period remain a crucial factor contributing to sustained reductions in depressive symptoms.
Authors: Kathleen J Sikkema; Krista W Ranby; Christina S Meade; Nathan B Hansen; Patrick A Wilson; Arlene Kochman Journal: J Consult Clin Psychol Date: 2012-10-01
Authors: Erin M Fekete; Michael H Antoni; Corina Lopez; Armando J Mendez; Angela Szeto; Mary Ann Fletcher; Nancy Klimas; Mahendra Kumar; Neil Schneiderman Journal: Psychoneuroendocrinology Date: 2011-01-06 Impact factor: 4.905
Authors: Corina R Lopez; Michael H Antoni; Deirdre Pereira; Julia Seay; Nicole Whitehead; Jonelle Potter; Maryjo O'Sullivan; Mary Ann Fletcher Journal: J Appl Biobehav Res Date: 2013-03-08
Authors: Erin M Fekete; Michael H Antoni; Corina R Lopez; Ron E Durán; Frank J Penedo; Frank C Bandiera; Mary Ann Fletcher; Nancy Klimas; Mahendra Kumar; Neil Schneiderman Journal: Brain Behav Immun Date: 2009-01-21 Impact factor: 7.217